Captopril In The Management of Heart Failure
DOI:
https://doi.org/10.47144/phj.v17i4.425Keywords:
Captopril In The Management of Heart FailureAbstract
MATERIAL & METHODS:
Criteria for Selection:
1. Patients with correctable cardiac disease but in refractory stage (e.g. inoperable chronic rheumatic heart disease, coronary artery disease).
2. Patients with incorrectable cardiac disease e.g. cárdiomyopathy.
3. Lschemic cardiac patients with associated incurable disease e.g. corpulmonale with Lschemic heart disease and liver disease.
DISCUSSION:
For the management of refractory cardiac failures, who do not respond adequately to the conventional therapy of digoxin and diuretics, new therapeutic modalities have now become available.It consists of control of venous return by decreasing “the preload” through the use of nitrates, or reduction of after load by hydrallazine which acts by peripheral arterial vasodilation.This series consisted of only of patient suffering from cardiac failures, and the dose of the drug required by them was much less than that which usual causes side effects.
Downloads
Downloads
How to Cite
Issue
Section
License
When an article is accepted for publication in the print format, the author will be required to transfer exclusive copyright to the PHJ and retain the rights to use and share their published article with others. However, re-submission of the full article or any part for publication by a third party would require prior permission of the PHJ.
Online publication will allow the author to retain the copyright and share the article under the agreement described in the licensing rights with creative commons, with appropriate attribution to PHJ. Creative Commons attribution license CC BY 4.0 is applied to articles published in PHJ https://creativecommons.org/licenses/by/4.0/
